前期或并发性恶性瘤与胃食道癌的整体存活率之间缺乏关联:来自欧洲大型单中心队列的证据
Hannah C Puhr1,2, Luzia Berchtold1,3, Linda Zingerle1,2
1Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
概括
在胃食道癌症病例中,癌症幸存者有其他恶性病史是常见的. 这种病史没有影响整体存活率,这表明在临床试验中更广泛的纳入.
科学领域:
- 癌症学
- 癌症生存率研究
- 临床试验资格
背景情况:
- 在癌症临床试验中,先前或同时出现的恶性瘤是常见的排除标准.
- 关于癌症存活率对胃食道癌症患者结果的影响的数据有限.
研究的目的:
- 研究其他恶性瘤病史与患者/瘤特征与胃食道癌患者的整体存活率之间的关联.
- 为了确定涉及胃食道癌幸存者的临床试验的资格标准.
主要方法:
- 在维也纳医学大学治疗的1491名胃食道癌症患者的回顾性分析.
- 检查患者特征,瘤特征,症状和整体生存期 (OS) 相关的先前或同时报告的恶性瘤.
主要成果:
- 18% 的患者有其他原发性癌症的病史.
- 其他恶性瘤的病史与年龄较大,状细胞组织学,局部瘤阶段较少的攻击性以及较少的酸性反流症状有关.
- 在其他恶性病史和整体存活率之间没有发现统计学意义上的关联.
结论:
- 在胃食道癌患者中,其他恶性疾病的病史普遍存在,并且不会对整体存活率产生负面影响.
- 癌症幸存者不应基于他们的生存状况而被彻底排除在临床试验之外.
- 需要进一步的前性研究来优化临床试验中癌症幸存者的资格标准.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
292
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
292
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Barrett Esophagus-I: Introduction
198
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
198
Esophageal Strictures-I: Introduction
264
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
264
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


